Earnings History Data for Eagle Pharmaceuticals, Inc. (EGRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2021	PM	6:50 AM ET (Aug 9)	EGRX	Eagle Pharmaceuticals, Inc.	610.03	0.27	0.21	-0.02	Eagle Pharmaceuticals EPS beats by $0.13, beats on revenue [8/9/2021 6:58 AM]	47.92	2.15 (4.70%)	45.77	0.0 (0.00%)	36.48 - 53.43	66,276	80,000	25,239
Eagle Pharmaceuticals Q2 2021 Earnings Preview [8/9/2021 4:05 AM] Eagle Pharmaceuticals EPS beats by $0.13, beats on revenue [8/9/2021 6:58 AM] Eagle Pharma in pact with AOP Orphan Pharma for heart disease therapy [8/9/2021 9:20 AM] Eagle Pharmaceuticals Reports Second Quarter 2021 Results [Aug-09-21 06:50AM] Eagle Pharmaceuticals Announces Licensing Agreement with AOP Orphan for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker [Aug-09-21 06:45AM] Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Surpass Estimates [Aug-09-21 08:05AM] Eagle Pharmaceuticals, inc (EGRX) Q2 2021 Earnings Call Transcript [Aug-09-21 04:30PM]
10-05-2021	PM	6:50 AM ET (May 10)	EGRX	Eagle Pharmaceuticals, Inc.	554.73	-0.03	0.20	0.41	Eagle Pharmaceuticals EPS misses by $0.49, misses on revenue [5/10/2021 6:51 AM]	38.39	-3.26 (-7.83%)	41.65	0.0 (0.00%)	36.48 - 56.16	79,987	90,000	1,164
Eagle Pharmaceuticals EPS misses by $0.49, misses on revenue [5/10/2021 6:51 AM] Eagle Pharmaceuticals, Inc. to Host Earnings Call [May-10-21 06:45AM] Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion ("RI") Liquid Formulation in Japan [May-10-21 06:45AM] Eagle Pharmaceuticals Reports First Quarter 2021 Results [May-10-21 06:50AM] Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates [May-10-21 08:05AM] Eagle Pharmaceuticals Inc (EGRX) Q1 2021 Earnings Call Transcript [May-10-21 11:30AM]
02-03-2021	PM	6:45 AM ET (Mar 2)	EGRX	Eagle Pharmaceuticals, Inc.	579.84	0.60	-1.42	0.18	Eagle Pharmaceuticals EPS beats by $1.16, misses on revenue [3/2/2021 6:56 AM]	40.69	-4.69 (-10.34%)	45.38	0.0 (0.00%)	33.80 - 56.16	168,043	124,979	1,406
Eagle Pharmaceuticals EPS beats by $1.16, misses on revenue [3/2/2021 6:56 AM] Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript [Mar-02-21 02:00PM]
02-11-2020	PM	6:50 AM ET (Nov 2)	EGRX	Eagle Pharmaceuticals, Inc.	600.34	0.51	0.02	-0.05	Eagle Pharmaceuticals EPS beats by $0.88, beats on revenue [11/2/2020 6:57 AM]	49.24	2.72 (5.86%)	46.52	0.0 (0.00%)	33.80 - 64.94	248,660	134,388	1,785

10-08-2020	PM	6:50 AM ET (Aug 10)	EGRX	Eagle Pharmaceuticals, Inc.	649.97	-0.02	-0.32	0.48	Eagle Pharmaceuticals EPS beats by $0.34, misses on revenue [8/10/2020 6:53 AM]	43.08	-3.92 (-8.34%)	45.07	-1.93 (-4.10%)	33.80 - 64.94	428,914	143,776	376